Nanoparticle-Based Immunotherapy for Cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Nanoparticle-Based Immunotherapy for Cancer

Published:2014-12-23 Issue:1 Volume:9 Page:16-30
ISSN:1936-0851
Container-title:ACS Nano
language:en
Short-container-title:ACS Nano

Author:

Shao Kun¹,Singha Santiswarup¹,Clemente-Casares Xavier¹,Tsai Sue¹,Yang Yang¹²,Santamaria Pere¹³

Affiliation:

1. Julia McFarlane Diabetes Research Centre (JMDRC) and Department of Microbiology, Immunology and Infectious Diseases, Snyder Institute for Chronic Diseases and Hotchkiss Brain Institute, Cummings School of Medicine, University of Calgary, Calgary, Alberta T2N 4N1 Canada

2. Department of Biochemistry and Molecular Biology, Cummings School of Medicine, University of Calgary, Calgary, Alberta T2N 4N1 Canada

3. Institut D’Investigacions Biomediques August Pi i Sunyer, Barcelona 08036, Spain

Funder

AXA Research Fund

Canadian Institutes of Health Research

Juvenile Diabetes Research Foundation International

Brawn Family Foundation

Natural Sciences and Engineering Research Council of Canada

Alberta Heritage Foundation for Medical Research

European Commission

Alberta Innovates - Technology Futures

Multiple Sclerosis Society of Canada

Publisher

American Chemical Society (ACS)

Subject

General Physics and Astronomy,General Engineering,General Materials Science

Link

https://pubs.acs.org/doi/pdf/10.1021/nn5062029

Reference127 articles.

1. Natural Innate and Adaptive Immunity to Cancer

2. Incidence and treatment of cancer in transplant recipients

3. Comparative incidence of cancer in HIV-AIDS patients and transplant recipients

4. Tumor-Specific Antigens and Immunologic Adjuvants in Cancer Immunotherapy

5. F-Actin Is an Evolutionarily Conserved Damage-Associated Molecular Pattern Recognized by DNGR-1, a Receptor for Dead Cells

Cited by 386 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Spatiotemporal Controllable Sono‐Nanovaccines Driven by Free‐Field Based Whole‐Body Ultrasound for Personalized Cancer Therapy;Advanced Science;2024-02-02

2. Advanced strategies for combinational immunotherapy of cancer based on polymeric nanomedicines;BMEMat;2024-01-12

3. Nanomedicine at the Pulmonary Frontier: Immune-Centric Approaches for Respiratory Disease Treatment;Immunological Investigations;2024-01-11

4. Nano-based vaccination and their administration routes in cancer immunotherapy;Nanomedicine in Cancer Immunotherapy;2024

5. Optimized DOX Drug Deliveries via Chitosan-Mediated Nanoparticles and Stimuli Responses in Cancer Chemotherapy: A Review;Molecules;2023-12-20

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3